Comparison of patients with high-risk nonmetastatic clear cell renal carcinoma in adjuvant therapy trials versus nonclinical trial patients.Jen Hoogenes, Anil Kapoor, Bimal Bhindi et al.|Journal of Clinical Oncology|2022Cited by 1